Publications by authors named "D K Acharya"

In this study, we built on the known inhibitory potential of diaminoquinazolines (DAQs) against different stages of Plasmodium development and designed a convenient two-step synthesis to combine DAQ with the primaquine (PQ) pharmacophore. The PQ-DAQ hybrids displayed potent in vitro activities in the low nanomolar range (IC50 of 135.20-398.

View Article and Find Full Text PDF

Background and objective RhD variants show altered D antigen expression, affecting their serological detection. Proper identification is crucial due to potential anti-D antibody formation. This study aimed to retrospectively analyze the frequency and characteristics of D variant cases encountered during RhD typing in both blood donors and recipients and the transfusion implications.

View Article and Find Full Text PDF

In this study, a comparison of biofilm formation, extracellular polymeric substances (EPS) production, protein and polysaccharides estimation, and protein profiling through SDS-PAGE, FTIR, GC-MS, ESI-MS, SEM, and AFM analysis were done for EPS from epilithic bacteria BC1 obtained from monumental rock under normal room temperature and heat stressed condition. Heat stress (60 ± 2 °C) that simulates hot monumental rock surfaces during the summer season caused  bacteria BC1 to produce more EPS (8.56 g/L), biofilm, protein and polysaccharides, extra SDS-PAGE protein bands of different molecular weight than their control counterpart.

View Article and Find Full Text PDF
Article Synopsis
  • Peripartum cardiomyopathy (PPCM) poses serious health risks, and while recovery of heart function is important, it doesn't guarantee better long-term outcomes; additional assessments using cardiac MRI (CMR) can reveal further risks.
  • The study analyzed 51 PPCM patients, highlighting that lower left ventricular ejection fraction (LVEF), peak global longitudinal strain (GLS), and higher extracellular volume (ECV) were linked to worse outcomes, including the need for heart assist devices or transplants.
  • Findings suggest CMR might help identify patients at higher risk for serious adverse outcomes beyond what LVEF can indicate, potentially revealing future treatment targets like diffuse myocardial fibrosis.
View Article and Find Full Text PDF